News & Articles

Johan Engström, Senior Scientist at Gyros Protein Technologies, discusses the challenges of measuring high-affinity interactions of ligands in cancer immunotherapy

Will enable cancer researchers to accelerate identification and optimization of therapeutic leads by better decoding KRAS mutations present in 25% of tumors

From tackling COVID-19 variants to therapeutic discovery, novel organoids and more, advance your assay research with these exclusive interviews and free resources

Dr. Erik Tillman shares his virtual company’s quest to find an effective new life-changing treatment for non-alcoholic steatohepatitis

The Synthetic Brain Project is using AI models powered by the Cambridge-1 supercomputer

The agreement will provide prevalidated hepatocytes for use on innovative organ-on-a-chip range

AMSBIO's new range avoid the need to source an expensive therapeutic product and enable fast and inexpensive assay development

Findings explain higher risk of heart attack in people with diabetes, even after treatment

The drug aims to treat patients with myelodysplastic syndromes

Largest review of all large-scale studies to date finds red and processed meat increase the risk of heart disease

This transaction will expand BioIVT’s biospecimen collection network by approximately 150 sites in the US, UK, and Europe and broaden its offerings for drug and diagnostic developers

The provision of high-quality cells that are known to grow successfully in 3D culture will help fast track organ-on-a-chip (OOC) adoption and customer research

Gain insights on hot topics ranging from respiratory virus testing to nano and quantum materials and automated LC-MS/MS workflows

Partnership includes initial upfront payments and will potentially deliver recurring revenues for over 10 years

The authorization enables emergency use of Actemra/RoActemra for the treatment of COVID-19 in hospitalized adult and pediatric patients

LGC has been working with NHS Test and Trace to support the UK's response to the pandemic

Watch this on-demand webinar to discover how neutralizing antibodies can be used as a drug modality for the treatment of COVID-19

Learn how the partnership between a Swedish molecular diagnostics company and a multinational CMO aims to standardize the quantification of important cancer biomarkers

The clinical data for Avacta’s AffiDX SARS-CoV-2 antigen lateral flow test demonstrated 100% sensitivity